Most of the sporadic colorectal cancer (CRC )develop from colorectal adenoma (CRA), patients
with CRA have a high risk of recurrence and development of metachronous CRA or CRC after
removal, therefore, the investigators conducted this clinical trial to explore the
chemoprevetion effect of metformin for CRA recurrence after removal.